BULIS VERONICA SANCHEZ (VP, Corporate Controller) sold 1.6% of their position (254.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $5.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0002095702-26-000002
Officer· VP, Corporate Controller
Since Feb 2026
+8.50K
Net shares
Net buyer
$5.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
8.75K acquired · 254.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.75K
Price / share
—
Trade value
—
% of position
122.5%
2/10/2026
7.14K→15.89K
Common Stock
Direct
Shares
−254.00
Price / share
$23.12
Trade value
$5.87K
% of position
1.6%
2/10/2026
15.89K→15.64K
Total
Net shares
+8.50K
Net value
-$5.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | A · Award | +8.75K | — | — | 122.5% | 7.14K | 15.89K |
| Common Stock Direct | 2/10/2026 | S · Sale | −254.00 | $23.12 | $5.87K | 1.6% | 15.89K | 15.64K |
| Total | +8.50K | -$5.87K | ||||||
Derivative Transactions0
No derivative transactions reported